1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of single agent bortezomib (VELCADE (R)) in patients with previously untreated multiple myeloma (MM)
    Meeting Abstract

    Richardson, P. G.; Chanan-Khan, A.; Schlossman, R. L.; Munshi, N. C.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A. L.; Lonial, S.; Hassoun, H.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma
    Meeting Abstract

    Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Possible association between hairy cell leukemia and Behcet's disease
    Journal Article

    Oo, T. R.; Delafuente, M.; Hassoun, H.
    Southern Medical Journal (2003)

    Fulltext@MSK | Save
  • Allopurinol-induced pure red cell aplasia
    Journal Article

    Shankar, P.; Aish, L.; Hassoun, H.
    American Journal of Hematology (2003)

    Fulltext@MSK | Save
  • Uncommon presentations of malignancies: Case 2. Carcinoid tumor presenting with bone marrow metastases
    Journal Article

    Oo, T. H.; Aish, L. S.; Schneider, D.; Hassoun, H.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
    Journal Article

    Dhodapkar, M. V.; Osman, K.; Teruya-Feldstein, J.; Filippa, D.; Hedvat, C. V.; Iversen, K.; Kolb, D.; Geller, M. D.; Hassoun, H.; Kewalramani, T.; more...
    Cancer Immunity (2003)

    Fulltext@MSK | Save